全球研究格局和乳头甲状腺癌治疗的趋势:一个文献计量分析
Bo Song1, Zheyu Lin1, Chuyao Feng1
1Department of Endocrinology and Metabolism, Institute of Endocrinology, National Health Commission Key Laboratory of Diagnosis and Treatment of Thyroid Diseases, The First Hospital of China Medical University, Shenyang, Liaoning, China.
Frontiers in endocrinology
|October 5, 2023
概括
这项研究分析了从2012年到2022年的乳头甲状腺癌 (PTC) 治疗研究趋势. 它揭示了人们越来越关注积极的监测和基因组分析,以及传统的治疗方法.
科学领域:
- 内分泌学 在内分泌学.
- 在瘤学瘤学.
- 图书统计学 图书统计学
背景情况:
- 乳头甲状腺癌 (PTC) 是全球最常见的内分泌恶性瘤.
- 现有的文献缺乏对PTC治疗研究的系统评估.
- 本研究通过参考资料和知识图分析来解决这一差距.
研究的目的:
- 系统地分析和绘制纸上甲状腺癌治疗的科学进展.
- 确定全球研究趋势,主要贡献者和PTC治疗中的新兴热门话题.
主要方法:
- 从科学核心集合网络 (2012-2022) 的出版物进行文献计量分析.
- 使用R软件,VOSviewer和CiteSpace进行数据分析.
- 审查的国家,机构,期刊,作者,参考文献和关键词.
主要成果:
- 在过去十年中,PTC疗法出版物和引用量稳步增加.
- 中国和美国在出版量方面领先;美国在引用方面领先.
- 新兴的研究领域包括积极监测,热废除和基因组分析.
结论:
- 参考文献分析提供了对PTC治疗研究趋势和热点的全面概述.
- 提供了关于PTC治疗的历史和当前景观的宝贵见解.
- 为该领域的科学家和临床医生指导未来的研究方向.
相关概念视频
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
01:27Tumor Immunotherapy
544
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
544
01:30Cancer Vaccines
389
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
389
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K